Effect of long-term clarithromycin therapy on prevention of pneumonia in older adults: A randomized, controlled trial.

Mari Yamasue Kosaku KomiyaHiroki YoshikawaYoshihisa KohnoYoshifumi ImamuraSatoshi OtaniTakehiko ShigenagaHironobu KogaKenji KishiTomoku IchimiyaHironori TanakaKanako HaraShingo NoguchiKazuhiro YateraHiroshi MukaeKazufumi HiramatsuJun-Ichi Kadota

Published in: Geriatrics & gerontology international (2019)

No statistically significant suppressive effects of long-term, low-dose macrolide therapy on the development of pneumonia among older people were found in this small sample. A large-scale, randomized, controlled study is required. Geriatr Gerontol Int 2019; 19: 1006-1009.

Keyphrases

low dose
helicobacter pylori
open label
physical activity
double blind
phase iii
intensive care unit
stem cells
clinical trial
placebo controlled
respiratory failure
cell therapy
mesenchymal stem cells
community acquired pneumonia
extracorporeal membrane oxygenation